LinaNova names its new CEO
Chief operating officer Damien McDonald will succeed André-Michel Ballester as chief executive at the end of the year.
Chief operating officer Damien McDonald will succeed André-Michel Ballester as chief executive at the end of the year.
London-based medical technology and innovation company LivaNova named Damien McDonald as the company’s new chief executive officer (CEO) and board member, effective January 1, 2017. McDonald currently serves as chief operating officer (COO), and succeeds André-Michel Ballester, who will resign at the end of this year. Ballester served as CEO of Sorin SpA from 2007 to 2015, prior to the October 2015 merger of Sorin and Cyberonics Inc. to create LivaNova.
McDonald was recently appointed COO, joining LivaNova from Danaher Corporation where he was group executive and corporate vice president. Before this, he was group president of Kerr where he and his team focused on building a strong research and development pipeline. Earlier roles included leading Zimmer’s spine division and working with J&J’s medical device franchises, including Ethicon.
Comments are closed.